Related Experiment Video
Updated: May 30, 2026
07:30
Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018
[Psychotropic drugs and diabetes]
Claudia Ress1, Alexander Tschoner, Susanne Kaser
1Department für Innere Medizin I, Medizinische Universität Innsbruck, Austria.
Wiener Medizinische Wochenschrift (1946)
|July 28, 2011
Summary
Psychotropic medications like antipsychotics and antidepressants can cause significant metabolic side effects, including weight gain and diabetes risk, impacting psychiatric patient health and treatment adherence. Understanding these risks is crucial for effective patient management.
Area of Science:
- Pharmacology and Psychiatry
- Metabolic Medicine
Background:
- Psychiatric patients face higher morbidity and mortality, partly due to psychotropic drug metabolic side effects.
- Antipsychotics and antidepressants are linked to adverse metabolic changes, including weight gain, dyslipidemia, and increased diabetes risk.
- A bidirectional relationship exists between diabetes and depression, complicating patient care.
Purpose of the Study:
- To review the metabolic side effects associated with commonly prescribed psychotropic medications.
- To explore the potential mechanisms underlying these metabolic disturbances.
- To highlight the clinical significance of managing these side effects for therapeutic success.
Main Methods:
- Literature review of studies on psychotropic drugs and their metabolic effects.
- Analysis of data concerning weight gain, glucose, and lipid metabolism alterations.
- Examination of the association between psychotropic drug use and diabetes risk.
Main Results:
- Antipsychotics commonly cause weight gain and dysregulate glucose and lipid metabolism, increasing diabetes risk.
- Certain antidepressants also correlate with elevated diabetes risk, though variations exist between substances.
- Significant inter-drug variability in metabolic side effect profiles is observed.
Conclusions:
- Metabolic side effects of psychotropic drugs are a major concern for psychiatric patients, affecting overall health and treatment outcomes.
- Effective management of these side effects is essential for improving patient compliance and therapeutic efficacy.
- Further research into underlying mechanisms can guide the development of safer psychotropic treatments.
Related Concept Videos
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:23Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...